Efficacy and Safety of Finerenone Combined with Dapagliflozin in the Treatment of Non-Diabetic Chronic Kidney Disease: A Single-Center Retrospective Study
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s564942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jianwei Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, People's Republic of China. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Renal Insufficiency, Chronic, Naphthyridines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, People's Republic of China.
- Department of Clinical Medicine, Tongji University School of Medicine, Shanghai, 200092, People's Republic of China.
- Health Science Center, Ningbo University, Ningbo, 315211, People's Republic of China.
ORCID-Profile: Guicai Fan
Zitieren
APA
Ma, J., Su, Q., Wang, H., Xu, J., Yuan, C., Fan, G., Ying, J., & Bian, X. (2026). Efficacy and Safety of Finerenone Combined with Dapagliflozin in the Treatment of Non-Diabetic Chronic Kidney Disease: A Single-Center Retrospective Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s564942
Vancouver
Ma J, Su Q, Wang H, Xu J, Yuan C, Fan G, et al. Efficacy and Safety of Finerenone Combined with Dapagliflozin in the Treatment of Non-Diabetic Chronic Kidney Disease: A Single-Center Retrospective Study. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s564942
BibTeX
@article{Ma2026,
author = {Ma, Jianwei and Su, Qin and Wang, Hanlu and Xu, Jiayan and Yuan, Chenyi and Fan, Guicai and Ying, Jiapei and Bian, Xueyan},
title = {Efficacy and Safety of Finerenone Combined with Dapagliflozin in the Treatment of Non-Diabetic Chronic Kidney Disease: A Single-Center Retrospective Study},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s564942}
}
EUVIMED